Victory Capital Management
FUSN

Victory Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Victory Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,390
Closed -$152K – 2737
2022
Q3 		$152K Sell
50,390
-131,010
-72% -$327K ﹤0.01% 2403
2022
Q2 		$451K Sell
181,400
-2,290
-1% -$10.5K ﹤0.01% 2102
2022
Q1 		$1.3M Sell
183,690
-66,690
-27% -$484K ﹤0.01% 1669
2021
Q4 		$1.04M Sell
250,380
-17,323
-6% -$108K ﹤0.01% 1812
2021
Q3 		$2.12M Sell
267,703
-1,920
-0.7% -$16.2K ﹤0.01% 1582
2021
Q2 		$2.18M Sell
269,623
-16,055
-6% -$138K ﹤0.01% 1609
2021
Q1 		$3.06M Buy
285,678
+106,154
+59% +$1.24M ﹤0.01% 1514
2020
Q4 		$2.11M Buy
179,524
+27,916
+18% +$351K ﹤0.01% 1502
2020
Q3 		$1.82M Sell
151,608
-32,117
-17% -$439K ﹤0.01% 1475
2020
Q2 		$3.21M Buy
+183,725
New +$3.2M ﹤0.01% 1285

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Victory Capital Management's FUSN Position: Q4 2022 in Review

Victory Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2022, closing a stake of 50,390 shares — an estimated $152K sold.

Victory Capital Management first reported a position in FUSN in Q2 2020 and held it in 10 quarters. The position peaked at $3.21M in Q2 2020. 30 funds tracked by Wall St. Rank hold FUSN as of Q4 2022.

  • Victory Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 50,390 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2022, an estimated $152K.
  • Victory Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 10 quarters.
  • Victory Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.21M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.